Hacker News new | past | comments | ask | show | jobs | submit login

Sounds economically big, in terms of who gets to monetize CRISPR ip.



Considering Doudna (one of the labs in question) also started Caribou Biosciences now worth $600M, yes, there is a lot at stake.

https://www.google.com/search?q=NASDAQ:+CRBU

https://www.cariboubio.com/about/#leadership


A big maybe at best. CRISPR might not achieve the humanity changing effect it might have any time soon.


It's still making a ton of money as its an excellent tool in the molecular biology lab.


It will be a slow takeoff like AI. It takes time for business applications to emerge. This is how all new tech works.

The businesses built around them have to grow and many will fail.




Join us for AI Startup School this June 16-17 in San Francisco!

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: